Results 121 to 130 of about 32,260 (226)

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1998
H. Yasuda   +15 more
semanticscholar   +1 more source

The Role of Micronutrients in Atherosclerosis: Mechanisms and Clinical Application

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 21, November 2025.
ABSTRACT Micronutrients, though required in relatively small quantities by the human body, are essential for maintaining normal physiological functions and play a crucial role in the prevention and management of various diseases. Atherosclerosis (AS) is a common chronic inflammatory condition that often presents without obvious symptoms in its early ...
Yuxin Ouyang   +5 more
wiley   +1 more source

Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

open access: yesCell, 1998
D. Lacey   +23 more
semanticscholar   +1 more source

Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption

open access: yesCell Reports, 2020
K. Cawley   +11 more
semanticscholar   +1 more source

Loss of SMN Impairs Osteoblast–Osteoclast Coupling via IGF1–Akt–OPG Axis in Spinal Muscular Atrophy

open access: yesThe FASEB Journal, Volume 39, Issue 20, 31 October 2025.
Loss of SMN impairs osteoblast–osteoclast coupling by disrupting the IGF1–Akt–OPG signaling axis, which leads to defective bone remodeling in spinal muscular atrophy. The graphical abstract highlights this molecular mechanism underlying skeletal pathology in SMA.
Taiyang Xiang   +7 more
wiley   +1 more source

Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

open access: yesCell, 1997
W. S. Simonet   +29 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy